
Sign up to save your podcasts
Or


In this episode, Steven Ringel, CEO of the Kizuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients.
By Scott Becker4.7
5858 ratings
In this episode, Steven Ringel, CEO of the Kizuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients.

21,189 Listeners

408 Listeners

398 Listeners

867 Listeners

1,394 Listeners

601 Listeners

210 Listeners

849 Listeners

233 Listeners

117 Listeners

147 Listeners

356 Listeners

85 Listeners

200 Listeners

137 Listeners